Please login to the form below
tuberculosis
This page shows the latest tuberculosis news and features for those working in and with pharma, biotech and healthcare.
Researchers discover new antibiotic using AI
That included showing efficacy against tuberculosis and strains of bacteria which are considered untreatable or resistant to currently approved antibiotics.
Latest news
-
GSK licenses its tuberculosis vaccine to Gates MRI
Vaccine has demonstrated around 50% efficacy in preventing disease. GlaxoSmithKline is out in front among efforts to develop a new vaccine against tuberculosis, but has decided it won’t take the
-
Antibiotic biotech Melinta files for bankruptcy
Certain infections, such as pneumonia, tuberculosis, blood poisoning, gonorrhoea and others are becoming resistant to standard antibiotics, making them increasingly hard-to-treat.
-
The NHS is facing shortages of lifesaving treatments, says internal document
In addition to identifying these new drug shortages, the document also revealed ongoing issues with 69 different types and doses of medication including antibiotics for tuberculosis, diamorphine, various cancer drugs, heart
-
GSK's pivotal TB vaccine could prevent millions of deaths
GlaxoSmithKline has announced that its IAVI-partnered experimental tuberculosis (TB) vaccine candidate significantly reduced the occurrence of pulmonary tuberculosis disease. . ... These final results show that M72/AS01E could be an important tool in
-
J&J pledges $500m investment into HIV and tuberculosis R&D
HIV and tuberculosis, with an aim to eliminate both diseases by 2030. .
More from news
Approximately 19 fully matching, plus 111 partially matching documents found.
Latest Intelligence
-
Risks, reforms and rewards: the evolving Russian healthcare market
Tuberculosis and Malaria.
-
COVID-19 hits supply chains
An FDA study found that at least three WHOdesignated ‘essential medicines’ are made from APIs sourced only in China: capreomycin and streptomycin, both used to treat tuberculosis; and sulfadiazine, used to
-
Biotech profile: Tom Evans, CEO, Vaccitech.
In September 2010 he joined Aeras, a non-profit Product Development Partnership with a mission to develop global tuberculosis vaccines, as the Chief Scientific Officer, and became CEO in February 2013.
-
Combining therapies and combining research
Combination therapy. Antibiotic Combination Therapy was developed in 1952 for the treatment of tuberculosis. ... Combination therapy is the norm in the treatment of many cancers and viral infections such as HIV and even some bacterial diseases such as
-
30 Women Leaders in UK Healthcare (part 3)
and tuberculosis around the world.
More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest appointments
-
Former Merck & Co exec to lead Seres
In total Dr Pomerantz has been involved with the development of eight approved drugs for infectious diseases, covering HIV, hepatitis C and tuberculosis.
-
GlycoVaxyn appoints Gerd Zettlmeissl as chairman
He currently serves on the boards of several biotechnology companies including Aeras, an organisation dedicated to the development of tuberculosis vaccines.
-
Former PEPFAR head Mark Dybul to lead the Global Fund
Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark Dybul as executive director.
More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Antibiotic resistance: The silent pandemic
The impact. An increasing number of common infections such as pneumonia, tuberculosis, gonorrhoea and salmonellosis are becoming harder to treat as antibiotics become less effective. ... The global statistics. 123 countries report extensive multi-drug
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
2. Characterised by very low levels of CD4+ T cells, and the presence of AIDS-related pathologies (such as tuberculosis and Kaposi’s sarcoma), the diagnosis of AIDS marks just how
-
Could ketamine be the next big thing in depression?
Doctors noticed that tuberculosis patients treated with isoniazid showed signs of improved mood.
-
Exploring MINT: Part 4 - Turkey
due to migration to the urban centres of the west. In Eastern Turkey, outbreaks of communicable diseases such as tuberculosis are still occurring. Pharma investment therefore remains focused on the western
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- China’s CanSino Biologics reveals phase 2 coronavirus vaccine results
- How will the events and exhibitions industry change post-Coronavirus?
- AbbVie, Roche’s Venclyxto combo reduces risk of death in first-line AML
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- Russia becomes first country to approve a COVID-19 vaccine
- Tecentriq combo fails in advanced triple negative breast cancer
- UK agrees on COVID-19 vaccine deals with J&J and Novavax
- COVID-19 vaccine approval unlikely before November, says US NIH director
- Calliditas bets on PBC drug in Genkyotex buyout
- Emotion-driven clinical trial marketing: A missed opportunity?
- Speed kills
- Unleashing the Potential of Multichannel Digital Strategies in Healthcare
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Emotion-driven clinical trial marketing: A missed opportunity?
- Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
- OPEN Health at the World Orphan Drug Conference USA
- Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Quick links
Infographics
